Abstract
Purpose: To ascertain the effect of perioperative application of high-dose of finasteride on prostatespecific antigen (PSA) in serum, tumor necrosis factor α (TNF-α) and interleukin-1β (IL-1β) in prostatic fluid of prostatic hyperplasia (BPH) patients with transurethral plasmakinetic resection of prostate (PKRP). Methods: In total, 141 BPH patients treated with PKRP in Hunan Provincial People’s Hospital, Changsha City, China from January 2015 to January 2017 were randomly divided into three groups of 47 cases each, viz, high-dose (10 mg of finasteride), low-dose (5 mg of finasteride), control (0 mg of finasteride). The levels of PSA in serum, as well as the levels of TNF-α and IL-1β in prostatic fluid were evaluated 7 days before and after surgery. Re-bleeding within 3 months after surgery in the three groups were performed and the patients observed. Results: Intra-operative bleeding volume, bleeding volume per unit resected tissue, and intra-operative volume of rinsing fluid were significantly less in high- and low-dose groups than those in the control group (p < 0.05); furthermore, the operation time was significantly shorter than that for the control group (p < 0.05). Seven days after surgery, international prostate symptom score (IPSS), serum PSA, and TNF-α and IL-1β in prostatic fluid of the high- and low-dose groups were significantly lower than those of the control group (p < 0.05). Also, maximum urine flow rate was significantly higher than that of the control group. Serum PSA, and TNF-α and IL-1β levels in prostatic fluid were significantly lower than those of low-dose group (p < 0.05). Serum PSA as well as TNF-α and IL-1β levels in prostatic fluid were positively correlated with IPSS score (r = 0.817, 0.838, 0.859, p < 0.001). The admission rate due to rebleeding was lowest in the high-dose group, followed by the low-dose group. Conclusion: Finasteride combined with PKRP for BPH acts synergistically to reduce serum PSA levels and local inflammatory reaction. High-dose finasteride/PKRP combination is more efficacious than the low-dose combination, thereby improving short-term prognosis in patients. Keywords: Finasteride, Transurethral plasmakinetic resection, Prostate, Prostate-specific antigen, Inflammatory factors
Highlights
Benign prostate hyperplasia (BPH) is one of the common diseases in middle-aged males
The best dose of the drug to be administered has not been made clear. On account of these shortcomings, a randomized controlled investigation was conducted in this study to unravel the curative effect of different doses of finasteride combined with plasmakinetic resection of prostate (PKRP) in treating BPH, and its impact on prostate specific antigen (PSA) and serum inflammatory factors
The operation time was significantly shorter in the high-dose group than that in the control group (p < 0.05), but there was no significant difference in these indices between the high- and the low-dose group (p > 0.05; Table 2)
Summary
Benign prostate hyperplasia (BPH) is one of the common diseases in middle-aged males. The best dose of the drug to be administered has not been made clear On account of these shortcomings, a randomized controlled investigation was conducted in this study to unravel the curative effect of different doses of finasteride combined with PKRP in treating BPH, and its impact on prostate specific antigen (PSA) and serum inflammatory factors. Inclusion criteria (1) Patients diagnosed as having BPH based on the standard "Guidelines for Diagnosis and Treatment of Urological Diseases of China (2014 version)" [11]; (2) Patient who presented evidence of PKRP, and agreed to be treated surgically; (3) Patients who did not receive antiandrogen drugs for the treatment of BPH within the previous 6 months; (4) Patients who had been informed of this study and had signed the "Informed Consent". Rebleeding situations after surgery were investigated within 3 months in the 2 groups
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
